TrueBlue Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TrueBlue stock.
View analyst ratings for TrueBlue or view top-rated stocks.

Wall Street analysts have given TrueBlue a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but TrueBlue wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

TrueBlue is scheduled to release its next quarterly earnings announcement on Monday, October 25th 2021.
View our earnings forecast for TrueBlue.

TrueBlue, Inc. (NYSE:TBI) released its earnings results on Sunday, July, 25th. The business services provider reported $0.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.39 by $0.08. The business services provider earned $515.96 million during the quarter. TrueBlue had a trailing twelve-month return on equity of 10.15% and a net margin of 2.01%.
View TrueBlue's earnings history.

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TBI shares have increased by 94.0% and is now trading at $25.90.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued 1 year price objectives for TrueBlue's stock. Their forecasts range from $16.00 to $29.00. On average, they anticipate TrueBlue's stock price to reach $23.00 in the next twelve months. This suggests that the stock has a possible downside of 11.2%.
View analysts' price targets for TrueBlue or view top-rated stocks among Wall Street analysts.

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to TrueBlue include Tradeweb Markets (TW), Robert Half International (RHI), ASGN (ASGN), ManpowerGroup (MAN), Insperity (NSP), Korn Ferry (KFY), Kforce (KFRC), Heidrick & Struggles International (HSII), Kelly Services (KELYA), Barrett Business Services (BBSI), GP Strategies (GPX) and Hudson Global (HSON).
View all of TBI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.28%), Vanguard Group Inc. (12.30%), Dimensional Fund Advisors LP (6.84%), Pzena Investment Management LLC (4.93%), FMR LLC (4.02%) and ArrowMark Colorado Holdings LLC (3.80%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper and Taryn R Owen.
View institutional ownership trends for TrueBlue.

TBI stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, BlackRock Inc., Dimensional Fund Advisors LP, Bank of America Corp DE, Prudential Financial Inc., Citadel Advisors LLC, Hotchkis & Wiley Capital Management LLC, and Cubist Systematic Strategies LLC. Company insiders that have sold TrueBlue company stock in the last year include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper, and Taryn R Owen.
View insider buying and selling activity for TrueBlue or view top insider-selling stocks.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Vanguard Group Inc., FMR LLC, Lord Abbett & CO. LLC, Invesco Ltd., Bank of Montreal Can, Parametric Portfolio Associates LLC, and Millennium Management LLC.
View insider buying and selling activity for TrueBlue or or view top insider-buying stocks.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TBI stock can currently be purchased for approximately $25.90.

TrueBlue has a market capitalization of $919.53 million and generates $1.85 billion in revenue each year. The business services provider earns $-141,840,000.00 in net income (profit) each year or $0.43 on an earnings per share basis.

TrueBlue employs 5,200 workers across the globe.

The official website for TrueBlue is www.trueblue.com.

TrueBlue is headquartered at 1015 A STREET, TACOMA WA, 98402.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at (253) 383-9101 or via email at [email protected].